Brendan Classon
Profile
Brendan Classon worked as a Director of Pharmacology at Regeneron Pharmaceuticals, Inc., a Director of Biopharmaceuticals Innovation Sourcing at Novo Nordisk A, and a Vice President of Research at Kiniksa Pharmaceuticals Ltd.
He holds a doctorate degree from the University of Melbourne and an undergraduate degree from Monash University.
Former positions of Brendan Classon
Companies | Position | End |
---|---|---|
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Chief Tech/Sci/R&D Officer | - |
REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
NOVO NORDISK A/S | Corporate Officer/Principal | - |
Training of Brendan Classon
Monash University | Undergraduate Degree |
University of Melbourne | Doctorate Degree |
Experiences
Positions held
Linked companies
Listed companies | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Brendan Classon